Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis

Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci.

1996 • 235 citations

Tumor Necrosis Factor‐α Contributes to Apoptosis in Hippocampal Neurons during Experimental Group B Streptococcal Meningitis

1997 • 112 citations

Oxidative Stress in Bacterial Meningitis

1999 • 109 citations

Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis

2000 • 84 citations

Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats.

1992 • 77 citations

Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury

1996 • 76 citations

Protective effect of the antioxidant N-acetyl-l-cysteine in pneumococcal meningitis in the rat

1997 • 66 citations

Neuroprotective Efficacy of Microvascularly-Localized Versus Brain-Penetrating Antioxidants

1996 • 62 citations

Role of glutathione conjugation in protection of weanling rat liver against acetaminophen-induced hepatotoxicity

1997 • 35 citations

Superoxide production by primary rat cerebral endothelial cells in response to pneumococci

1999 • 34 citations

Tirilazad Widens the Therapeutic Window for Riluzole-Induced Attenuation of Progressive Cortical Degeneration in an Infant Rat Model of the Shaken Baby Syndrome

1998 • 33 citations

Protective Effect of a 21-Aminosteroid during Experimental Pneumococcal Meningitis

1995 • 24 citations

POTENTIAL THERAPEUTIC VALUE OF LAZAROIDS IN ENDOTOXEMIA AND OTHER FORMS OF SEPSIS

1997 • 20 citations

Clinically achievable plasma deferoxamine concentrations are therapeutic in a rat model of Pneumocystis carinii pneumonia

1995 • 18 citations

Cited By (0)

Loading...